Cardiotoxicity in the SCID mouse following administration of doxorubicin and cyclosporin A

Anti-Cancer Drugs

Volumn 6, Issue 6, 1995, Pages 736-743

  Bellamy, W T ^a   Peng, Y M ^a   Odeleye, A ^a   Ellsworth, L ^a   Xu, M J ^a   Grogan, T M ^a   Weinstein, R S ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

MDR; Multiple myeloma; SCID mouse

Indexed keywords

CREMOPHOR; CYCLOSPORIN A; DOXORUBICIN; DRUG VEHICLE; IMMUNOSUPPRESSIVE AGENT; MULTIDRUG RESISTANCE REVERSAL AGENT; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CARDIOTOXICITY; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOTOXICITY; DRUG TISSUE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; MULTIDRUG RESISTANCE; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; XENOGRAFT;

EID: 0029563319     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199512000-00004     Document Type: Article

References (0)